66 related articles for article (PubMed ID: 3592625)
21. Disparity between expression of transferrin receptor ligand binding and non-ligand binding domains on human lymphocytes.
Boldt DH; Phillips JL; Alcantara O
J Cell Physiol; 1987 Aug; 132(2):331-6. PubMed ID: 3624319
[TBL] [Abstract][Full Text] [Related]
22. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
Yang GY; Shamsuddin AM
Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of uptake of transferrin-bound iron by human hepatoma cells by nontransferrin-bound iron.
Trinder D; Morgan E
Hepatology; 1997 Sep; 26(3):691-8. PubMed ID: 9303500
[TBL] [Abstract][Full Text] [Related]
24. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
Picon A; Gold LI; Wang J; Cohen A; Friedman E
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
[TBL] [Abstract][Full Text] [Related]
25. Analyses for binding of the transferrin family of proteins to the transferrin receptor 2.
Kawabata H; Tong X; Kawanami T; Wano Y; Hirose Y; Sugai S; Koeffler HP
Br J Haematol; 2004 Nov; 127(4):464-73. PubMed ID: 15521925
[TBL] [Abstract][Full Text] [Related]
26. The blockage of the human transferrin receptor by a monoclonal antibody, EA.3, induces growth inhibition in leukemia cell lines.
Valentini M; Gregorini A; Bartolucci M; Porcellini A; Papa S
Eur J Histochem; 1994; 38 Suppl 1():61-8. PubMed ID: 8547712
[TBL] [Abstract][Full Text] [Related]
27. Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.
Matusiak D; Glover S; Nathaniel R; Matkowskyj K; Yang J; Benya RV
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G718-28. PubMed ID: 15528253
[TBL] [Abstract][Full Text] [Related]
28. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells.
Periyasamy S; Sun L; Gentry LE; Brattain MG
J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
30. Transferrin receptor expression in reactive and neoplastic lesions of lymphnodes.
Singh S; Singh M; Kalra R; Marwah N; Chhabra S; Arora B
Indian J Pathol Microbiol; 2007 Apr; 50(2):433-6. PubMed ID: 17883102
[TBL] [Abstract][Full Text] [Related]
31. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
33. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines.
Wang W; Heideman L; Chung CS; Pelling JC; Koehler KJ; Birt DF
Mol Carcinog; 2000 Jun; 28(2):102-10. PubMed ID: 10900467
[TBL] [Abstract][Full Text] [Related]
34. Selection of tumor-specific internalizing human antibodies from phage libraries.
Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD
J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812
[TBL] [Abstract][Full Text] [Related]
35. Expression of transferrin receptors in human erythroleukemic lines: regulation in the plateau and exponential phase of growth.
Testa EP; Testa U; Samoggia P; Salvo G; Camagna A; Peschle C
Cancer Res; 1986 Oct; 46(10):5330-4. PubMed ID: 3463412
[TBL] [Abstract][Full Text] [Related]
36. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.
Al-Ayyoubi S; Gali-Muhtasib H
Mol Carcinog; 2007 Mar; 46(3):176-86. PubMed ID: 17192871
[TBL] [Abstract][Full Text] [Related]
37. Murine cell surface transferrin receptor: studies with an anti-receptor monoclonal antibody.
Trowbridge IS; Lesley J; Schulte R
J Cell Physiol; 1982 Sep; 112(3):403-10. PubMed ID: 6290505
[TBL] [Abstract][Full Text] [Related]
38. Integrin alpha3beta1 expressed by human colon cancer cells is a major carrier of oncodevelopmental carbohydrate epitopes.
Prokopishyn NL; Puzon-McLaughlin W; Takada Y; Laferté S
J Cell Biochem; 1999 Feb; 72(2):189-209. PubMed ID: 10022502
[TBL] [Abstract][Full Text] [Related]
39. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
40. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
